Scoutby Fusion42
Open Imperagen in the live Scout dashboard →

Explore: Biotech · Seed · United Kingdom

Imperagen

seed · 🇬🇧 Manchester, United Kingdom · Founded 2021 · 11-50 employees

Website

Biotech company using quantum physics and AI to improve enzyme engineering by making it faster, more efficient, and less costly. Imperagen is a biotech and deeptech startup based in Manchester, United Kingdom, founded 2021, at seed stage, with $6.7M raised to date.

Imperagen is tracked live on Scout, Fusion42's database of newly funded startups — its profile updates as new rounds, backers and Wire analysis land.

Total raised

$6.7M

Stage

seed

Business model

SaaS

Key differentiator

Its closed-loop Digital Enzyme Evolution platform combines AI-led protein design with QM/physics-based simulation and high-throughput robotics to deliver verified enzyme improvements faster and more predictably.

Target customer

Pharmaceutical manufacturers, life sciences companies, and industrial/fine chemical companies needing custom enzyme optimization and development

Sectors

biotechdeeptechhealthtechSaaSautomation

Funding rounds

seed

20 May 2026

$6.7M

Led by PXN Ventures

With IQ Capital and Northern Gritstone

Round details →Source ↗

Key investors

IQ Capital, Northern Gritstone

Notable achievements

Backed by

Team enrichment — names, roles, LinkedIn, X and email where availableSign in to view

Frequently asked questions

What does Imperagen do?
Biotech company using quantum physics and AI to improve enzyme engineering by making it faster, more efficient, and less costly.
Where is Imperagen based?
Imperagen is based in Manchester, United Kingdom, founded in 2021.
How much has Imperagen raised?
Imperagen has raised $6.7M in tracked funding and is currently at the seed stage.
Who has invested in Imperagen?
Investors in Imperagen include IQ Capital and Northern Gritstone.